查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495421

治療診斷學市場：按產品、應用和最終用戶 - 2024-2030 年全球預測

Theranostics Market by Product (Product, Services, Software), Application (Bone Metastatis, Cardiovascular Diseases, Lymphoma), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年治療診斷學市場規模為23.3億美元，預計2024年將達26.7億美元，2030年將達61.8億美元，複合年成長率為14.89%。

治療診斷學代表了一個創新的醫學領域，它將診斷與基於診斷測試結果的標靶治療相結合。這種方法可以實現個人化治療，透過根據個人的疾病特徵量身定做治療，從而實現更有效率、更有效的醫療保健服務。治療診斷學的主要用途包括腫瘤學、心血管疾病、神經系統疾病和感染疾病。治療診斷學的最終用戶主要是醫院和診所、診斷實驗室和研究機構，它們可以透過整合治療和診斷過程來顯著改善患者護理。由於全球目標疾病的盛行率不斷增加，對治療診斷學的需求也不斷增加。個人化醫療的不斷成長趨勢和分子生物學的進步正在擴大治療診斷學的使用。此外，醫療保健基礎設施的成長和全球研發活動投資的增加是治療診斷學市場成長的主要驅動力。與研發相關的高成本、與資料隱私相關的問題以及個人化醫療的倫理考量對市場成長構成了重大挑戰。新生物標記、非侵入性成像技術和精準治療藥物的開拓預計將帶來市場成長機會。資料分析和機器學習的集合成為開發患者反應預測模型、最佳化治療方法和監測疾病進展提供了前沿。

主要市場統計
基準年[2023] 23.3億美元
預測年份 [2024] 26.7億美元
預測年份 [2030] 61.8億美元
複合年成長率（%） 14.89%

區域洞察

美洲是治療診斷學市場開拓高度發展的地區，其特點是醫療保健支出高、專利註冊力度大以及對個人化醫療的大量投資。人們對個人化醫療益處的認知不斷提高，以及公共和私營部門對治療診斷學研究和應用的投資不斷增加，預計將在美洲建立市場基礎。在歐盟（EU），監管支持以及強大的醫療保健系統正在推動治療診斷學市場的成長。德國、法國和英國等國家處於前沿，其研究重點是癌症和神經退化性疾病。在醫療保健基礎設施投資以及與西方生物技術公司合作的推動下，中東地區重新表達了興趣。非洲在重點提供可及的診斷服務方面具有潛力，特別是在衛生系統發達的地區。在政府推動個人化醫療創新措施的推動下，亞太地區正迅速成為治療診斷學的關鍵地區。隨著日本人口老化，對先進治療診斷解決方案的需求日益成長，特別是在癌症和心血管疾病方面。隨著印度醫療保健產業的不斷發展以及對平價醫療的重視，對社區治療研究和合作研究的投資正在增加。

FPNV定位矩陣

FPNV 定位矩陣對於評估供應商在治療診斷學市場的定位至關重要。此矩陣提供了對供應商的全面評估，並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對治療診斷學市場中供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該領域競爭性質的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在治療診斷學市場中的地位進行全面評估，使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球目標疾病的盛行率正在增加
      • 個人化醫療與分子生物學的進展
    • 抑制因素
      • 研發成本高、監理核准複雜
    • 機會
      • 加強治療診斷學中資料分析和機器學習的整合
      • 新生物標記和非侵入性成像技術的開發仍在繼續
    • 任務
      • 資料隱私和個人化醫療的倫理考量
  • 市場區隔分析
    • 產品：更多地使用軟體進行資料收集、處理和分析
    • 最終使用者：擴大醫院治療診斷學在各種疾病管理的潛力
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章治療診斷學市場：依產品

  • 產品
  • 服務
  • 軟體

第7章治療診斷學市場：依應用分類

  • 骨轉移
  • 心血管疾病
  • 淋巴瘤
  • 神經內分泌腫瘤
  • 攝護腺癌

第8章治療診斷學市場：依最終使用者分類

  • 癌症護理中心
  • 醫院
  • 研究學術中心
  • 治療診斷學中心

第9章美洲治療診斷學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太治療治療診斷學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的治療診斷學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Clarity 的前列腺癌藥物臨床試驗在最高劑量水平隊列中取得進展
    • BAMF Health 和 GE Healthcare 合作，為治療診斷學的發展提供永續、可擴展的解決方案
    • 加州大學洛杉磯分校健康中心開設治療診斷學中心
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-61081604A0A5

[194 Pages Report] The Theranostics Market size was estimated at USD 2.33 billion in 2023 and expected to reach USD 2.67 billion in 2024, at a CAGR 14.89% to reach USD 6.18 billion by 2030.

Theranostics represents an innovative field in medical science that combines diagnostics with targeted therapy based on diagnostic test results. This approach enables personalized treatment, allowing for more efficient and effective healthcare delivery by tailoring treatment to the individual's specific disease characteristics. The primary applications of theranostics include oncology, cardiovascular diseases, neurological disorders, and infectious diseases, among others. The end-users of theranostics are largely hospitals and clinics, diagnostic laboratories, and research institutions, where the integration of therapeutic and diagnostic processes can significantly enhance patient care. The increasing prevalence of target diseases worldwide is expanding the need for theranostics. The growing inclination towards personalized medicines and rising advancements in molecular biology are expanding the usage of theranostics. Additionally, the growth of healthcare infrastructure and increasing investments in R&D activities globally serve as key drivers for the growth of the theranostics market. High costs associated with R&D and issues related to data privacy and the ethical considerations of personalized medicine pose significant challenges to market growth. Growing development of novel biomarkers, non-invasive imaging techniques, and precision therapeutics are expected to create opportunities for market growth. The integration of data analytics and machine learning presents a frontier for developing predictive models for patient response, optimizing treatment regimens, and monitoring disease progression.

KEY MARKET STATISTICS
Base Year [2023] USD 2.33 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 6.18 billion
CAGR (%) 14.89%

Regional Insights

The Americas represents a highly developing landscape for theranostics market development, characterized by high healthcare expenditure, robust patent registrations, and significant investments in personalized medicine. Growing awareness of personalized healthcare benefits with rising public and private sector investments for research and application in theranostics are expected to create a platform for the market in the Americas. In the European Union (EU), regulatory support, along with strong healthcare systems, promotes the growth of the theranostics market. Countries including Germany, France, and the UK are at the forefront, with research centered on oncology and neurodegenerative diseases. The Middle East shows emerging interest, propelled by investments in healthcare infrastructure and partnerships with Western biotech firms. Africa displays potential particularly in regions with developing healthcare systems, focusing on accessible diagnostic services. Asia Pacific is rapidly emerging as a significant region in the theranostics field, backed by government initiatives aimed at boosting innovation in personalized medicine. Japan's aging population drives need for advanced theranostic solutions, particularly in oncology and cardiovascular diseases. India, with its growing healthcare sector and focus on affordable care, is witnessing increased investment in localized theranostic research and collaborations.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Theranostics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing prevalence of target diseases globally
      • Rising advancements in personalized medicine and molecular biology
    • Market Restraints
      • High costs associated with R&D and the complexity of regulatory approvals
    • Market Opportunities
      • Increasing integration of data analytics and machine learning in theranostics
      • Growing development of novel biomarkers and non-invasive imaging techniques
    • Market Challenges
      • Data privacy and the ethical considerations of personalized medicine
  • Market Segmentation Analysis
    • Product: Rising usage of software for data acquisition, processing, and analysis
    • End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Theranostics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Theranostics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort

Clarity Pharmaceuticals announced the positive progression of its phase I/IIa SECuRE trial, evaluating the novel theranostic agent 64Cu/67Cu-SAR-bisPSMA in metastatic castration-resistant prostate cancer (mCRPC) patients. In the latest update, the trial's cohort 3, operating under a 3+3 study design, treated three participants with the highest dose of 12GBq of 67Cu-SAR-bisPSMA, demonstrating promising safety and efficacy outcomes. This advancement, along with continued positive outcomes, particularly under the FDA's Expanded Access Program (EAP), underscores SAR-bisPSMA's promise to improve treatment outcomes for prostate cancer patients. [Published On: 2023-11-29]

BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics

GE Healthcare and BAMF Health have collaborated to accelerate the adoption of theranostic solutions across the U.S., emphasizing the importance of innovative technologies and services to enhance patient care. By integrating GE HealthCare's comprehensive solutions and BAMF Health's expertise in molecular imaging and theranostics, this partnership is poised to establish a robust framework for the deployment of precision medicine. [Published On: 2023-11-13]

UCLA Health to Open Theranostics Center

UCLA Health is gearing up to launch its pioneering outpatient theranostics center later this year, marking a significant milestone in the treatment of advanced cancer. This state-of-the-art 3,000-square-foot facility situated on the Westwood campus's 100 Medical Plaza building is designed to optimize patient care. With eight infusion chairs, the center aims to deliver up to 80 transfusions weekly, amounting to 4,000 treatment cycles annually, primarily focusing on patients with advanced prostate cancer, neuroendocrine tumors, and thyroid cancer. [Published On: 2023-05-22]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Theranostics Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Theranostics Market, highlighting leading vendors and their innovative profiles. These include Actinium Pharmaceuticals, Inc., Ariceum Therapeutics GmbH, Astellas Pharma Inc., BAMF Health, Bayer AG, bioMerieux SA, Biosynth Ltd., Cardinal Health, Inc., Cerebral Therapeutics, Inc., Clarity Pharmaceuticals, Curasight A/S, Curium Inc., Evergreen Theragnostics, Inc., GE HealthCare Technologies, Inc., Hermes Medical Solutions AB, Icon Group, Indi Molecular, Inc., Integrated Clinical Oncology Network Pty Ltd., Invicro, LLC, Ipsen Pharma, Radiopharm Theranostics Limited, Ratio Therapeutics, Siemens Healthineers AG, SOFIE Co., Telix Pharmaceuticals Limited, and United Theranostics.

Market Segmentation & Coverage

This research report categorizes the Theranostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Product
      • Diagnostic Imaging
        • Functional Imaging
        • Molecular Imaging
        • Nuclear Imaging
      • In Vitro Diagnostics/Biomarker Screening
        • Fluorescence In Situ Hybridization
        • Next-generation Sequencing
        • Polymerase Chain Reaction
      • Radiopharmaceuticals
        • Fluorine-18
        • Gallium-68
        • lodine-131
        • Lutetium-177
        • Radium-223
        • Samarium-153
        • Strontium-89
        • Technetium-99
        • Yttrium-90
    • Services
    • Software
      • Imaging Analytics
      • Predictive Modeling
  • Application
    • Bone Metastatis
    • Cardiovascular Diseases
    • Lymphoma
    • Neuroendocrine Tumors
    • Prostate Cancer
  • End-User
    • Cancer Care Centers
    • Hospitals
    • Research & Academic Centers
    • Theranostics Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of target diseases globally
      • 5.1.1.2. Rising advancements in personalized medicine and molecular biology
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with R&D and the complexity of regulatory approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing integration of data analytics and machine learning in theranostics
      • 5.1.3.2. Growing development of novel biomarkers and non-invasive imaging techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy and the ethical considerations of personalized medicine
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising usage of software for data acquisition, processing, and analysis
    • 5.2.2. End-User: Growing potential of theranostics among hospitals for the management of a variety of diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Theranostics Market, by Product

  • 6.1. Introduction
  • 6.2. Product
  • 6.3. Services
  • 6.4. Software

7. Theranostics Market, by Application

  • 7.1. Introduction
  • 7.2. Bone Metastatis
  • 7.3. Cardiovascular Diseases
  • 7.4. Lymphoma
  • 7.5. Neuroendocrine Tumors
  • 7.6. Prostate Cancer

8. Theranostics Market, by End-User

  • 8.1. Introduction
  • 8.2. Cancer Care Centers
  • 8.3. Hospitals
  • 8.4. Research & Academic Centers
  • 8.5. Theranostics Centers

9. Americas Theranostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Theranostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Theranostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Clarity's Theranostic Prostate Cancer Trial Progresses at the Highest Dose Level Cohort
    • 12.3.2. BAMF Health and GE HealthCare Collaborate to Enable Sustainable and Scalable Solutions for Growth in Theranostics
    • 12.3.3. UCLA Health to Open Theranostics Center
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. THERANOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. THERANOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. THERANOSTICS MARKET DYNAMICS
  • FIGURE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THERANOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. THERANOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. THERANOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. THERANOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL THERANOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL THERANOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL THERANOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL THERANOSTICS MARKET SIZE, BY FUNCTIONAL IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL THERANOSTICS MARKET SIZE, BY MOLECULAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL THERANOSTICS MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL THERANOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL THERANOSTICS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL THERANOSTICS MARKET SIZE, BY FLUORINE-18, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL THERANOSTICS MARKET SIZE, BY GALLIUM-68, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL THERANOSTICS MARKET SIZE, BY LODINE-131, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL THERANOSTICS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL THERANOSTICS MARKET SIZE, BY RADIUM-223, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL THERANOSTICS MARKET SIZE, BY SAMARIUM-153, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL THERANOSTICS MARKET SIZE, BY STRONTIUM-89, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL THERANOSTICS MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL THERANOSTICS MARKET SIZE, BY YTTRIUM-90, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL THERANOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL THERANOSTICS MARKET SIZE, BY IMAGING ANALYTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL THERANOSTICS MARKET SIZE, BY PREDICTIVE MODELING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL THERANOSTICS MARKET SIZE, BY BONE METASTATIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL THERANOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL THERANOSTICS MARKET SIZE, BY LYMPHOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL THERANOSTICS MARKET SIZE, BY NEUROENDOCRINE TUMORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL THERANOSTICS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL THERANOSTICS MARKET SIZE, BY CANCER CARE CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL THERANOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL THERANOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL THERANOSTICS MARKET SIZE, BY THERANOSTICS CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 97. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 98. AMERICAS THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 99. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. AMERICAS THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 104. AMERICAS THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 111. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 112. ARGENTINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 113. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 114. ARGENTINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 115. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 116. ARGENTINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 117. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. ARGENTINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. ARGENTINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 126. BRAZIL THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 127. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 128. BRAZIL THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 129. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 130. BRAZIL THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 131. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 132. BRAZIL THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 133. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. BRAZIL THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. BRAZIL THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. CANADA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 142. CANADA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 143. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 144. CANADA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 145. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 146. CANADA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 147. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 148. CANADA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 149. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. CANADA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. CANADA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. MEXICO THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 158. MEXICO THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 159. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 160. MEXICO THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 161. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 162. MEXICO THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 163. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 164. MEXICO THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 165. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. MEXICO THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. MEXICO THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 170. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 171. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. UNITED STATES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 174. UNITED STATES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 175. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 176. UNITED STATES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 177. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 178. UNITED STATES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 179. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 180. UNITED STATES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 181. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. UNITED STATES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED STATES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED STATES THERANOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC THERANOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 206. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. AUSTRALIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 210. AUSTRALIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 212. AUSTRALIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 214. AUSTRALIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 216. AUSTRALIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. AUSTRALIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. AUSTRALIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 224. CHINA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 225. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 226. CHINA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 227. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 228. CHINA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 229. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 230. CHINA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 231. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 232. CHINA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 233. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. CHINA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. CHINA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. INDIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 242. INDIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 243. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 244. INDIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 245. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 246. INDIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 247. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 248. INDIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 249. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 250. INDIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 251. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. INDIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 254. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 255. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. INDONESIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 258. INDONESIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 259. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 260. INDONESIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 261. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 262. INDONESIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 263. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 264. INDONESIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 265. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. INDONESIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. INDONESIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 272. JAPAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 273. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 274. JAPAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 275. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 276. JAPAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 277. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 278. JAPAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 279. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 280. JAPAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 281. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. JAPAN THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. JAPAN THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. MALAYSIA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 290. MALAYSIA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 291. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 292. MALAYSIA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 293. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 294. MALAYSIA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 295. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 296. MALAYSIA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 297. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. MALAYSIA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 300. MALAYSIA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 301. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. PHILIPPINES THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 306. PHILIPPINES THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 307. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 308. PHILIPPINES THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 309. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 310. PHILIPPINES THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 311. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 312. PHILIPPINES THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 314. PHILIPPINES THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 316. PHILIPPINES THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 317. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 318. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 319. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. SINGAPORE THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 322. SINGAPORE THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 323. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 324. SINGAPORE THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 325. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 326. SINGAPORE THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 327. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 328. SINGAPORE THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 329. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. SINGAPORE THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 332. SINGAPORE THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 333. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. SOUTH KOREA THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 338. SOUTH KOREA THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 339. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 340. SOUTH KOREA THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 341. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 342. SOUTH KOREA THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 343. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 344. SOUTH KOREA THERANOSTICS MARKET SIZE, BY SOFTWARE, 2024-2030 (USD MILLION)
  • TABLE 345. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. SOUTH KOREA THERANOSTICS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. SOUTH KOREA THERANOSTICS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 350. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 351. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 352. TAIWAN THERANOSTICS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 353. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2023 (USD MILLION)
  • TABLE 354. TAIWAN THERANOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING, 2024-2030 (USD MILLION)
  • TABLE 355. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2018-2023 (USD MILLION)
  • TABLE 356. TAIWAN THERANOSTICS MARKET SIZE, BY IN VITRO DIAGNOSTICS/BIOMARKER SCREENING, 2024-2030 (USD MILLION)
  • TABLE 357. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2018-2023 (USD MILLION)
  • TABLE 358. TAIWAN THERANOSTICS MARKET SIZE, BY RADIOPHARMACEUTICALS, 2024-2030 (USD MILLION)
  • TABLE 359. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWARE, 2018-2023 (USD MILLION)
  • TABLE 360. TAIWAN THERANOSTICS MARKET SIZE, BY SOFTWAR